Three-dimensional Structure of a Mutant HIV-1 Protease Displaying Cross-resistance to All Protease Inhibitors in Clinical Trials
Open Access
- 1 September 1995
- journal article
- research article
- Published by Elsevier BV
- Vol. 270 (37), 21433-21436
- https://doi.org/10.1074/jbc.270.37.21433
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Protease uninhibitedNature, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Dissociation and association of the HIV-1 protease dimer subunits: Equilibria and ratesBiochemistry, 1994
- [3] Host strain selection for bacterial expression of toxic proteinsMethods in enzymology, 1994
- High-level resistance to zidovudine but not to zalcitabine or didanosine in human immunodeficiency virus from children receiving antiretroviral therapyThe Journal of Pediatrics, 1993
- STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASEAnnual Review of Biochemistry, 1993
- The three-dimensional structure of the aspartyl protease from the HIV-1 isolate BRUBiochimie, 1991
- Functional group contributions to drug-receptor interactionsJournal of Medicinal Chemistry, 1984
- α-Chymotrypsin: A Case Study of Substituent Constants and Regression Analysis in Enzymic Structure—Activity RelationshipsJournal of Pharmaceutical Sciences, 1970